Log in | Register

Home
All Journals
Breast Cancer: Targets and Therapy
List of Issues
Volume 16, Issue null

Breast Cancer: Targets and Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Cover image for Breast Cancer: Targets and Therapy, Volume 16, 2024

Breast Cancer: Targets and Therapy, Volume 16, Issue (2024)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

Breast Cancer: Targets and Therapy, Volume 16, Issue (2024)

See all volumes and issues

Volume 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Issue In Progress

ORIGINAL RESEARCH

Article

Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab

Qingqing Gu, Mingzhi Zhu, Yanyan Wang & Yuanting Gu

Pages: 253-268

Published online: 25 May 2024

AbstractforRetrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab | Full Text | References | PDF (5.6 MB) | EPUB

4 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC)

Xulei Sui, Peipei Feng, Xiaoyuan Sun, Peng Liang, Ying Liu & Guowei Zhang

Pages: 245-252

Published online: 24 Apr 2024

AbstractforCorrelation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC) | Full Text | References | PDF (550.7 KB) | EPUB

31 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Expression and Significance of LINC02418 in Breast Cancer

Yong-Hong Zhou & Jian-Yuan Huang

Pages: 233-243

Published online: 24 Apr 2024

AbstractforExpression and Significance of LINC02418 in Breast Cancer | Full Text | References | PDF (6.8 MB) | EPUB

29 Views
0 CrossRef citations
0Altmetric

Open Access

CLINICAL TRIAL REPORT

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial

Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Ji-Bin Li, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen-Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan & Qian-Jun Chen

Pages: 223-231

Published online: 12 Apr 2024

AbstractforDoes the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial | Full Text | References | PDF (1.1 MB) | EPUB

69 Views
0 CrossRef citations
0Altmetric

Open Access

LETTER

Letter to the Editor

Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]

Febie Irsandy Syahruddin, Prihantono & Mirna Muis

Pages: 221-222

Published online: 10 Apr 2024

CitationforSerum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter] | Full Text | References | PDF (272.6 KB) | EPUB

31 Views
0 CrossRef citations
0Altmetric

Open Access

ORIGINAL RESEARCH

Article

Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer

Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu & Yi-Xin Qi

Pages: 199-219

Published online: 12 Apr 2024

AbstractforIdentification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer | Full Text | References | PDF (19.8 MB) | EPUB

73 Views
0 CrossRef citations
0Altmetric

Open Access

REVIEW

Review

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review

Meixi Ye, Hao Xu, Jinhua Ding & Li Jiang

Pages: 181-197

Published online: 10 Apr 2024

AbstractforTherapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review | Full Text | References | PDF (1.7 MB) | EPUB

89 Views
0 CrossRef citations
0Altmetric

Open Access

ORIGINAL RESEARCH

Article

Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients

Shuling Wang, Yuqin Chen, Weidong Li, Chunfang Hao, Li Zhang, Weipeng Zhao, Yehui Shi & Zhongsheng Tong

Pages: 163-179

Published online: 03 Apr 2024

AbstractforSerum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients | Full Text | References | PDF (9 MB) | EPUB

91 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer

Michelle Marie Ubowski, Ryan VanSice, Morgan Marriott, Matthew J Yacobucci & Lipika Chablani

Pages: 149-162

Published online: 28 Mar 2024

AbstractforAmplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer | Full Text | References | PDF (6.1 MB) | EPUB

70 Views
0 CrossRef citations
0Altmetric

Open Access

Article

HER2 Low Expression in Primary Male Breast Cancer

Katleen Nobbe, Melanie Erices-Leclercq, Frank Foerster, Robert Förster, Stephan E Baldus, Christian Rudlowski, Lars Schröder & Sabine Lubig

Pages: 141-148

Published online: 28 Mar 2024

AbstractforHER2 Low Expression in Primary Male Breast Cancer | Full Text | References | PDF (2.3 MB) | EPUB

129 Views
0 CrossRef citations
0Altmetric

Open Access

Article

ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer

Nelson Rangel, Iris Lorena Sánchez, Duván Sebastián Valbuena & Milena Rondón-Lagos

Pages: 127-139

Published online: 15 Mar 2024

AbstractforZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer | Full Text | References | PDF (5.9 MB) | EPUB

80 Views
0 CrossRef citations
0Altmetric

Open Access

Article

The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients

Qin Ma, Yao-Bang Liu, Tong She & Xin-Lan Liu

Pages: 117-126

Published online: 08 Mar 2024

AbstractforThe Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients | Full Text | References | PDF (2.9 MB) | EPUB

117 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

Sarah Sharman Moser, Lior Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, Gabriel Chodick & Nava Siegelmann-Danieli

Pages: 105-116

Published online: 05 Mar 2024

AbstractforClinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting | Full Text | References | PDF (1.7 MB) | EPUB

112 Views
0 CrossRef citations
0Altmetric

Open Access

Article

An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery

Qi Li, Cong Gao, Xinrui Zhao, Jiahui Li, Qinghong Shen & Li Chen

Pages: 91-103

Published online: 05 Mar 2024

AbstractforAn Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery | Full Text | References | PDF (1.2 MB) | EPUB

106 Views
0 CrossRef citations
0Altmetric

Open Access

Article

GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer

Yuying Zhou, Wu Xue, Xinyu Meng, Adheesh Bhandari, Hanqian Zeng, Rajan KC, Suzita Hirachan & Erjie Xia

Pages: 71-89

Published online: 05 Mar 2024

AbstractforGNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer | Full Text | References | PDF (14.7 MB) | EPUB

92 Views
0 CrossRef citations
0Altmetric

Open Access

REVIEW

Review

Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads

Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fêde, Gustavo de Oliveira Bretas, Cristiano de Pádua Souza, Max Mano & Jesse Lopes da Silva

Pages: 51-70

Published online: 27 Feb 2024

AbstractforAntibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads | Full Text | References | PDF (1.8 MB) | EPUB

378 Views
0 CrossRef citations
0Altmetric

Open Access

ORIGINAL RESEARCH

Article

Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study

Fardeen Bhimani, Sophie Lin, Maureen McEvoy, Arianna Cavalli, Liane Obaid, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Areej Shihabi & Sheldon Feldman

Pages: 41-50

Published online: 20 Feb 2024

AbstractforDoes Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study | Full Text | References | PDF (1.7 MB) | EPUB

104 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer

Chia‐Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu & Ching-Ting Wei

Pages: 23-39

Published online: 15 Jan 2024

AbstractforPretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer | Full Text | References | PDF (2.5 MB) | EPUB

170 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer

Jian Jin, Jie Li, Yonghong Liu, Qingfeng Shi, Bo Zhang, Yanting Ji & Pengfei Hu

Pages: 15-22

Published online: 08 Jan 2024

AbstractforThyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer | Full Text | References | PDF (2 MB) | EPUB

285 Views
0 CrossRef citations
0Altmetric

Open Access

Article

The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors

Suheyla Ekemen, Ebru Bilir, Hagar Elsayed Akram Soultan, Sadia Zafar, Figen Demir, Babek Tabandeh, Sadik Toprak, Ozlem Yapicier & Cevayir Coban

Pages: 1-13

Published online: 02 Jan 2024

AbstractforThe Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors | Full Text | References | PDF (4.1 MB) | EPUB

240 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab

Qingqing Gu et al.

Article | Published online: 25 May 2024

Open Access

Expression and Significance of LINC02418 in Breast Cancer

Yong-Hong Zhou et al.

Article | Published online: 24 Apr 2024

Open Access

Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC)

Xulei Sui et al.

Article | Published online: 24 Apr 2024

Open Access

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial

Ying Chen et al.

Published online: 12 Apr 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Breast Cancer: Targets and Therapy (Vol.16, Iss., 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?